0001437749-21-013626.txt : 20210528
0001437749-21-013626.hdr.sgml : 20210528
20210528083049
ACCESSION NUMBER: 0001437749-21-013626
CONFORMED SUBMISSION TYPE: 5/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20210528
DATE AS OF CHANGE: 20210528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byrne Joseph A.
CENTRAL INDEX KEY: 0001736911
FILING VALUES:
FORM TYPE: 5/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 21976289
MAIL ADDRESS:
STREET 1: 6 CAMERON SIDE ROAD EAST
CITY: ESSEX
STATE: A6
ZIP: N8M 2X5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
5/A
1
rdgdoc.xml
FORM 5/A
X0306
5/A
2017-12-31
2021-04-26
0
1
0001653821
CEN BIOTECH INC
CENBF
0001736911
Byrne Joseph A.
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
Chief Executive Officer*
Common Stock
2017-11-30
4
A
0
L
20000
0
A
1353265
D
Common Stock
2017-11-30
4
A
0
L
1250000
0
A
1353265
D
1,270,000 shares of common stock of the Issuer were granted by the issuer to the reporting person on November 30, 2017, pursuant to two restricted stock agreements pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
1,353,265 shares were beneficially owned by the Reporting Person of which 76,123 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.
The reporting person served as the Chief Executive Officer and member of the Board of the Issuer from July 2017 until November 13, 2019, when the reporting person resigned from all positions with the Issuer. The reporting person was appointed as President and a member of the Board of the Issuer effective April 19, 2021.
/s/ Joseph Byrne
2021-05-28